Shares of BioCryst Pharmaceuticals BCRX are higher on the session by 9.65%, currently trading at $3.41. The stock has been moving largely higher over the past three weeks and is currently trading above the 50-day moving average.
Options traders are focusing on calls today. A short while ago the September 2011 $4.00 call traded 570 times on open interest of 664 contracts.
Calls are outpacing puts today by 50 to 1.
BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops novel drugs that block enzymes involved in cancer, viral infections and autoimmune diseases.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in